You are here

The SAGE Handbook of Healthcare
Share

The SAGE Handbook of Healthcare



May 2008 | 752 pages | SAGE Publications Ltd
With escalating healthcare costs, changes to the regulatory control on pharmaceutical industries and the inevitable adjustments made in policies and investment in healthcare there is enormous interest in the commercial as well as the scientific aspects of today's healthcare industry.

The SAGE Handbook of Healthcare provides an authoritative analysis of the current (and anticipated) developments in the global healthcare industries. Providing a unique perspective that interfaces between the science and business aspects, it combines information on the latest scientific developments with applied, commercial business data from the global marketplace.

The Handbook focuses on the aspects of paramount importance in the healthcare sector:

- Pharmacoeconomics

- Pharmacogenomics

- Therapeutics

- Diagnostics

Areas covered include:

- The role of nanotechnology, genomics and cell therapy in medicine

- Diagnostics; Biomarkers and technological advances

- Case studies in oncology and cardiovascular and CNS therapeutics

 
PART ONE: PHARMACOECONOMICS
 
Medicare Part D
An Outlook  
 
Changes in US Oncology Drug Reimbursement
Medicare Sets The Pace  
 
Prospective Payment Systems
Opportunities and Threats for the Pharmaceutical Industry  
 
Off-label Prescribing
Overcoming the Reimbursement Barrier  
 
Pricing and Reimbursement Issues in Neurology
 
Authorized Generics
Look Before You Leap  
 
Pharmaceutical Pricing and Reimbursement in Canada
 
Contrasting European and US Patent Laws
Issues for the Pharmaceutical Industry  
 
The Changing Face of European Drug Registration
 
The Impact of Reference Pricing in Europe
 
Pharmaceutical Pricing, Reimbursement, and Prescribing in the United Kingdom
 
Pharmaceutical Pricing, Reimbursement, and Prescribing in Italy
 
Pharmaceutical Pricing, Reimbursement, and Prescribing in Spain
 
The Impact of German Reference Pricing on Statins
 
Opportunities and Challenges in the Japanese Market for Cancer Therapies
 
Cancer Therapies Face Increasing Reimbursement Pressures in Europe and Japan
 
The Pharmaceutical Pricing and Reimbursement Environment in China
 
Will Point of Care Come of Age by 2010?
 
PART TWO: PHARMACOGENOMICS
 
Has Genomics Failed to Deliver?
 
The Role of Pharmacogenomics in Personalized Medicine
 
Cell Therapy
A Decade of Opportunity  
 
Nanotechnology in Medicine
Its Time Has Come  
 
Clinical Proteomics
An Engine for In Vitro Diagnostics Growth?  
 
PART THREE: THERAPEUTICS
 
Oncology
 
Novel Strategies in Oncology Clinical Trials
The Use of Biological and Imaging Biomarkers  
 
Antitumor Biologics
Strategies for Success in an Expanding Market  
 
Outlook for Cancer Vaccine Development
 
Advances Imminent in Antiangiogenesis Therapeutics
 
Discoveries and Challenges in Early-stage Apoptosis Drug Development
 
Chronic Lymphocytic Leukemia
Monoclonal Antibodies Will Drive Steady Growth  
 
CNS
 
Opportunities in the Pharmacotherapy of Addiction
 
Immunology
 
Prevention of Organ Transplant Rejection
Current Therapies and Novel Strategies  
 
Cardiovascular
 
Cardiovascular Drugs and Devices Market
Some Successes and Setbacks in Recent Years  
 
Renin Inhibitors
A Novel Approach to Hypertension  
 
Future of VLA-4 Antagonist Drugs and Implications for the Regulatory Process
 
Impact of Inhaled Insulin on the Insulin Market
 
Impact of the PROactive Study on the Treatment of Type 2 Diabetes
 
PART FOUR: DIAGNOSTICS
 
Integrating Diagnostics and Therapeutics for Targeted Therapies
 
Part 1: Optimizing the Comarketing Plan
 
Integrating Diagnostics and Therapeutics for Targeted Therapies
 
Part 2: The Importance of Calculating the Return on Investment
 
Emerging Diagnostic Markers in Alzheimer's Disease
 
How are Translational Medicine Biomarkers Impacting Industry?
 
Unlocking the Potential of Biomarkers in Targeted Oncology
 
From Bioterrorism to Predictive Medicine: New Applications of Salivary Diagnostics

Preview this book

For instructors

This book is not available as an inspection copy. For more information contact your local sales representative.

Purchasing options

Please select a format:

ISBN: 9781847870483
£135.00

SAGE Knowledge is the ultimate social sciences digital library for students, researchers, and faculty. Hosting more than 4,400 titles, it includes an expansive range of SAGE eBook and eReference content, including scholarly monographs, reference works, handbooks, series, professional development titles, and more.

The platform allows researchers to cross-search and seamlessly access a wide breadth of must-have SAGE book and reference content from one source.

SAGE Knowledge brings together high-quality content from across our imprints, including CQ Press and Corwin titles.